Trial
NCT02147873
Study of Azacitidine With or Without Birinapant in Subjects With MDS or CMMoL
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
TetraLogic Pharmaceuticals
Collaborators
—
Condition
Myelodysplastic Syndrome (MDS)
Intervention
birinapant
Why stopped
Study terminated due to lack of efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-10-20